In a recently published study from our group, the antisense lncRNA HOXA10-AS was identified as an essential regulator of hematopoiesis and as a novel oncogenic lncRNA in the context of pediatric AML with KMT2A rearrangements (KMT2A-r AML) [70]. Here, KMT2A is linked to acute myeloid leukemia.